Bausch Health [BHC] vs Amneal [AMRX] Detailed Stock Comparison

Bausch Health Companies Inc.

NYSE
Loading...

Amneal Pharmaceuticals Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Bausch Health Companies Inc. wins in 17 metrics, Amneal Pharmaceuticals Inc. wins in 3 metrics, with 0 ties. Bausch Health Companies Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bausch Health Companies Inc. Amneal Pharmaceuticals Inc. Better
P/E Ratio (TTM) 13.19 63.23 Bausch Health Companies Inc.
Price-to-Book Ratio 5.58 -57.42 Bausch Health Companies Inc.
Debt-to-Equity Ratio 5,591.25 45,095.52 Bausch Health Companies Inc.
PEG Ratio -0.06 -0.30 Bausch Health Companies Inc.
EV/EBITDA 6.69 10.64 Bausch Health Companies Inc.
Profit Margin (TTM) 1.53% 2.39% Amneal Pharmaceuticals Inc.
Operating Margin (TTM) 25.79% 14.06% Bausch Health Companies Inc.
EBITDA Margin (TTM) 25.79% 14.06% Bausch Health Companies Inc.
Return on Equity 436.36% -101.02% Bausch Health Companies Inc.
Return on Assets (TTM) 5.18% 7.32% Amneal Pharmaceuticals Inc.
Free Cash Flow (TTM) $993.00M $225.64M Bausch Health Companies Inc.
1-Year Return -15.38% 109.03% Amneal Pharmaceuticals Inc.
Price-to-Sales Ratio (TTM) 0.20 1.47 Bausch Health Companies Inc.
Enterprise Value $22.75B $6.86B Bausch Health Companies Inc.
EV/Revenue Ratio 2.22 2.27 Bausch Health Companies Inc.
Gross Profit Margin (TTM) 71.46% 36.50% Bausch Health Companies Inc.
Revenue per Share (TTM) $28 $10 Bausch Health Companies Inc.
Earnings per Share (Diluted) $0.42 $0.22 Bausch Health Companies Inc.
Beta (Stock Volatility) 0.40 1.32 Bausch Health Companies Inc.
Short % of Float 2.00% 3.47% Bausch Health Companies Inc.

Bausch Health Companies Inc. vs Amneal Pharmaceuticals Inc. Stock Performance Analysis

Loading Price Chart...

BHC
AMRX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bausch Health Companies Inc.-1.38%-2.35%-7.93%-0.80%-27.79%-30.79%
Amneal Pharmaceuticals Inc.0.25%18.45%36.13%36.01%30.34%28.28%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bausch Health Companies Inc.-15.38%-31.16%-82.74%-77.04%-89.99%-77.64%
Amneal Pharmaceuticals Inc.109.03%497.79%211.54%10.20%10.20%10.20%

Performance & Financial Health Analysis: Bausch Health Companies Inc. vs Amneal Pharmaceuticals Inc.

MetricBHCAMRX
Market Information
Market Cap i$2.10B$4.15B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i1,154,6891,402,990
90 Day Avg. Volume i1,376,9661,913,723
Last Close$4.99$16.24
52 Week Range$4.93 - $8.69$7.66 - $16.61
% from 52W High-42.58%-2.23%
All-Time High$263.81 (Aug 03, 2015)$24.48 (Aug 20, 2018)
% from All-Time High-98.11%-33.66%
Growth Metrics
Quarterly Revenue Growth0.09%0.12%
Quarterly Earnings GrowthN/A0.11%
Financial Health
Profit Margin (TTM) i0.02%0.02%
Operating Margin (TTM) i0.26%0.14%
Return on Equity (TTM) i4.36%-1.01%
Debt to Equity (MRQ) i5,591.2545,095.52
Cash & Liquidity
Book Value per Share (MRQ)$-1.50$-0.23
Cash per Share (MRQ)$3.53$0.91
Operating Cash Flow (TTM) i$1.40B$339.99M
Levered Free Cash Flow (TTM) i$1.09B$197.07M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Bausch Health Companies Inc. vs Amneal Pharmaceuticals Inc.

MetricBHC (Apr 26, 2026)AMRX (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i13.1963.23
Forward P/E i1.3711.78
PEG Ratio i-0.06-0.30
Price to Sales (TTM) i0.201.47
Price to Book (MRQ) i5.58-57.42
Market Capitalization
Market Capitalization i$2.10B$4.15B
Enterprise Value i$22.75B$6.86B
Enterprise Value Metrics
Enterprise to Revenue i2.222.27
Enterprise to EBITDA i6.6910.64
Risk & Other Metrics
Beta i0.401.32
Book Value per Share (MRQ) i$-1.50$-0.23

Financial Statements Comparison: Bausch Health Companies Inc. vs Amneal Pharmaceuticals Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBHC (2025)AMRX (2025)
Revenue/Sales i10.27B3.02B
Cost of Goods Sold i3.01B1.91B
COGS % of Revenue i29.3%63.1%
Gross Profit i7.25B1.11B
Gross Margin i70.7%36.9%
Research & Development i629.00M193.81M
Operating Income (EBIT) i2.19B397.91M
Operating Margin i21.3%13.2%
EBITDA i3.44B606.64M
EBITDA Margin i33.5%20.1%
Pre-Tax Income i367.00M139.21M
Pre-Tax Income % of Revenue i3.6%4.6%
Income Tax i247.00M11.28M
Income Tax % of Revenue i2.4%0.4%
Net Income (Profit) i120.00M127.93M
Profit Margin i1.2%4.2%

Balance Sheet & Liquidity Metrics

MetricBHC (2025)AMRX (2025)
Cash & Equivalents i1.31B282.03M
Total Current Assets i6.16B1.91B
Total Current Assets % of Revenue i60.0%63.3%
Total Current Liabilities i4.18B881.63M
Total Current Liabilities % of Revenue i40.7%29.2%
Long-Term Debt i20.62B2.67B
Long-Term Debt % of Revenue i200.8%88.4%
Total Shareholders Equity i377.00M-71.33M
Retained Earnings i-9.67B-535.01M
Retained Earnings % of Revenue i-94.2%-17.7%
Property, Plant & Equipment i112.00M107.38M

Cash Flow Statement Comparison

MetricBHC (2025)AMRX (2025)
Operating Cash Flow i1.36B256.93M
Operating Cash Flow % of Revenue i13.3%8.5%
Capital Expenditures i-397.00M-96.75M
Free Cash Flow i993.00M225.64M
FCF Margin i9.7%7.5%
Debt Repayment i-11.19B-2.81B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBHCAMRX
Shares Short i5.99M7.19M
Short Ratio i2.673.18
Short % of Float i2.00%3.47%
Shares Outstanding i370.53M314.57M
Float Shares i258.52M176.28M
% Held by Insiders i30.41%44.04%
% Held by Institutions i65.20%49.74%
% Held by Public i4.39%6.22%

Dividend Analysis & Yield Comparison: Bausch Health Companies Inc. vs Amneal Pharmaceuticals Inc.

MetricBHCAMRX
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00N/A
Ex-Dividend DateN/AN/A